Tech juggernaut Apple Inc. has teamed up with neurotechnology firm Synchron to pioneer innovative products like iPhones and iPads that could eventually be operated through brain implants, signaling a bold step toward integrating cutting-edge neural interfaces with everyday devices.
This initiative is focused on helping individuals with physical disabilities control their Apple devices using thought commands. The technology leverages Synchron’s stent-like implant, which is positioned on the motor cortex of the brain, enabling seamless interaction with iPhones and iPads through neural signals.
The device, known as Stentrode, captures motor signals from the brain and sends them wirelessly to an external processor, which then translates these signals into commands for electronic devices.
Apple and Stentrode plan to integrate their technologies by enhancing the tech firm’s current assistive switch control system, which enables users with limited mobility to operate iPhones hands-free through simple gestures such as head movements or silent sounds. This collaboration aims to expand accessibility options by combining brain-controlled commands with established device controls.
Related: Avatar’s James Cameron Calls Generative AI ‘Horrifying’ and a Threat to Actors
Individuals affected by conditions like amyotrophic lateral sclerosis (ALS) or severe spinal cord injuries may significantly improve their ability to operate smartphones and tablets using thought alone, bypassing the need for physical movement.
Furthermore, future users interested in the Stentrode device will avoid open brain surgery, as Synchron describes the technology as a minimally invasive and scalable brain-computer interface (BCI).
“With BCI recognised as a native input for Apple devices, there are new possibilities for people living with paralysis and beyond,” Synchron co-founder Tom Oxley stated. “Apple is helping to pioneer a new interface paradigm, where brain signals are formally recognised alongside touch, voice and typing,” he added.
Related: Navigating The Nexus
Limited trials involving Apple’s iPhones, iPads, and Apple Vision Pro mixed-reality headsets are scheduled to commence with select participants later this year.
As Apple and Synchron move forward with these trials, the collaboration could mark a significant milestone in merging neuroscience and consumer technology, potentially redefining how users interact with digital devices in the near future.
